Larynx cancer: quality of life and voice after treatment

Rossi, Vaneli Colombo; Fernandes, Fernando Laffitte; Ferreira, Maria Augusta Aliperti; Bento, Lucas Ricci; Pereira, Pablo Soares Gomes; Chone, Carlos Takahiro

doi:10.1016/j.bjorl.2014.07.005

Acessibilidade / Reportar erro

Brasil

Brazilian Journal of Otorhinolaryngology

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Articles • Braz. j. otorhinolaryngol. 80 (5) • Sep-Oct 2014 • https://doi.org/10.1016/j.bjorl.2014.07.005 copy

Larynx cancer: quality of life and voice after treatment ^☆ ☆ Please cite this article as: Rossi VC, Fernandes FL, Ferreira MA, Bento LR, Pereira PS, Chone CT. Larynx cancer: quality of life and voice after treatment. Braz J Otorhinolaryngol. 2014;80:403-8. ^☆☆ ☆☆ Institution: Discipline of Speech Therapy and Otorhinolaryngology, Head and Neck; Faculdade de Ciências Médicas (FCM) Hospital das Clínicas (HC) - Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.

Authorship SCIMAGO INSTITUTIONS RANKINGS

INTRODUCTION:

Treatment for patients with larynx cancer often results in a negative impact on their physical, social and psychological functions.

OBJECTIVE:

To evaluate quality of life and voice in patients treated for advanced laryngeal cancer as a consequence of surgery or exclusive chemoradiation.

METHODS:

Retrospective cohort study with 30 patients free of disease: 10 total laryngectomy patients without production of esophageal speech (EVS); 10 Total laryngectomy patients with tracheoesophageal voice (TEV) and 10 patients with laryngeal voice. Quality of life was measured by SF-36; Voice-Related Quality of Life (V-RQOL) and Voice Handicap Index (VHI) protocols, applied on the same day.

RESULTS:

The SF-36 demonstrated that patients who received chemoradiotherapy exclusively enjoyed a feature better quality of life than the group of TEV and EVS. In V-RQOL it was observed that the quality of life related to voice is lower than in the EVS. In the VHI group EVS presented higher scores for overall VHI, emotional, functional and organic.

DISCUSSION:

Quality of life and voice in patients treated with chemoradiotherapy was better than in patients treated surgically.

CONCLUSION:

The type of medical treatment selected in patients with laryngeal cancer can influence changes in quality of life and voice.

Laryngeal neoplasms; Voice; Squamous cell carcinoma

	G1 (no voice)	G2 (TES)	G3 (laryngeal voice)	p ^a
Age	65.8	65.10	61.60	0.534
Functional capacity	85.0	84.50	88.50	0.970
Physical aspects	65.0	100	77.50	0.100
Pain	68.6	81.80	90.10	0.035
Overall health status	84.10	87.50	88.30	0.847
Vitality	90.0	81.50	74.50	0.054
Social aspects	95.0	100	83.50	0.152
Emotional aspects	63.33	93.33	80.0	0.230
Mental health	86.80	83.60	76.40	0.199

	G1 (no voice)	G2 (TES)	G3 (laryngeal voice)	p ^a
Total QVV	43.45	78.0	93.50	0.001
Total physical	48.13	84.38	96.25	0.031
Total emotional	41.63	73.73	90.83	0.001

	G1 (no voice)	G2 (TES)	G3 (laryngeal voice)	p ^a
Total handicap	40.30	10.80	4.90	0.001
Emotional handicap	11.90	3.40	0.80	0.001
Functional handicap	19.60	5.20	2.10	0.001
Organic handicap	9.30	2.20	1.40	0.002

	n	Mean	p ^a
Self-assessment	20	1.95	–
ST 1	20	1.55	0.021
ST 2	20	1.95	1.000
ST 3	20	1.50	0.003
ST 4	20	1.50	0.003
Mean STs	–	1.62	–

Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Sede da Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico Facial, Av. Indianópolia, 1287, 04063-002 São Paulo/SP Brasil, Tel.: (0xx11) 5053-7500, Fax: (0xx11) 5053-7512 - São Paulo - SP - Brazil
E-mail: revista@aborlccf.org.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] * Corresponding author. E-mail: vanelicolombo@ig.com.br (V.C. Rossi).